Suvanza Pharma, LLC (SUVZ) Investment Research Dashboard
About Suvanza Pharma, LLC (SUVZ) stock analysis
Get live SUVZ stock price $0.00, comprehensive Suvanza Pharma, LLC stock analysis, charts, news, sentiment, sector analysis, and expert forecast. Real-time SUVZ stock data and investment insights.
Loading chart data...
Investment Score
A systematic tri-factor framework (valuation, quality, momentum) using trailing twelve-month fundamentals and current price momentum—aligned with the full investment score dashboard.
Score unavailable for this asset.
0-39
Defensive posture
40-54
Mixed / wait for confirmation
55-69
Constructive setup
70-100
Attractive zone
Total Score
Value
Cheapness vs fundamentals and cash generation
Quality
Durability of profitability and balance sheet
Momentum
Price trend strength and persistence
Company Overview
Suvanza Pharma, LLC is an emerging biotechnology enterprise dedicated to developing RapiDerm, an innovative drug delivery system applied to the skin, specifically targeting dermatological disorders. The company, which began operations in 2004 and is ...
Company Information
- CEO
- Nardo Zaias
- Sector
- Healthcare
- Industry
- Biotechnology
- Employees
- 0
Contact Information
- Website
- https://www.suvanza.com
- Address
- 5401 Collins Avenue
- Country
- US
Investment Analysis & Business Insights
Investment Highlights
✓ Strong presence in the Healthcare sector with established market position
✓ Lower volatility stock (Beta: 0.59) may provide portfolio stability
Important Investment Considerations
- ⚠All investments carry risk, including potential loss of principal for Suvanza Pharma, LLC shareholders
- ⚠Market volatility can significantly impact stock price, especially for smaller companies
- ⚠Sector-specific risks in Healthcare may affect company performance
- ⚠Past performance does not guarantee future results for Suvanza Pharma, LLC
- ⚠Investors should consider how Suvanza Pharma, LLC fits within their overall portfolio allocation
Market Cap
1.01M
Beta
0.59
Data Sources & Methodology
Financial data on this page is sourced from verified SEC EDGAR filings (10-K, 10-Q, 8-K reports), real-time market data providers, and official company disclosures. All analysis is generated using AI models trained exclusively on reliable financial documents. For detailed information about our data sources and methodology, see our Methodology page.Not investment advice.
Related Stocks
Compare SUVZ with peer companies:
- Price
- $0.01-65.33% (1D)
- Market cap
- 1.09M
- Price
- $1.16+0.00% (1D)
- Market cap
- 518.24K
- Price
- $0.00+0.00% (1D)
- Market cap
- 859.73K
- Price
- N/A
- Market cap
- N/A
- Price
- $0.00+0.00% (1D)
- Market cap
- 1.07M
- Price
- $0.37+0.00% (1D)
- Market cap
- 1.15M
- Price
- $0.01+0.00% (1D)
- Market cap
- 727.91K
- Price
- $0.01+0.00% (1D)
- Market cap
- 885.39K
- Price
- $0.16+0.00% (1D)
- Market cap
- 1.18M
- Price
- $0.06+450.46% (1D)
- Market cap
- 651.82K
About Healthcare Sector
The Healthcare sector includes companies that provide medical services, develop pharmaceuticals, manufacture medical devices, and offer health insurance.
Healthcare (1D)
80/100 ⭐⭐⭐⭐⭐
- Overall
- +0.7%
- NYSE
- +0.6%
- NASDAQ
- +0.7%
| Sector | 1D | 1W | 1M | P/E | Score |
|---|---|---|---|---|---|
| Financial Services | +2.2% | +5.7% | +6.1% | 19.3 | 98/100⭐⭐⭐⭐⭐ |
| Communication Services | +1.4% | +2.9% | +4.3% | 22.2 | 86/100⭐⭐⭐⭐⭐ |
| Healthcare | +0.7% | +3.3% | +3.5% | 24.1 | 80/100⭐⭐⭐⭐⭐ |
| Basic Materials | +0.4% | +1.1% | -0.2% | 25.2 | 56/100⭐⭐⭐⭐ |
| Consumer Defensive | -0.2% | +1.7% | +1.2% | 29.7 | 56/100⭐⭐⭐⭐ |
| Real Estate | -0.5% | -0.1% | -1.6% | 29.2 | 43/100⭐⭐⭐ |
| Energy | -2.1% | -5.8% | -5.1% | 19.1 | 39/100⭐⭐ |
| Utilities | -1.0% | -3.0% | -5.9% | 26.8 | 28/100⭐⭐ |
| Industrials | +0.6% | +1.7% | -11.2% | 30.1 | 26/100⭐⭐ |
| Consumer Cyclical | +0.5% | -0.4% | -6.3% | 43.0 | 21/100⭐ |
| Technology | +0.6% | -2.3% | -9.6% | 40.7 | 17/100⭐ |
Sector returns combine NYSE and NASDAQ averages. P/E is the latest blended sector multiple. Sector score ranks each sector vs peers using percentile ranks (not fixed thresholds): 48% 1M + 24% 1W + 8% 1D + 20% P/E (lower P/E ranks higher). Data as of 2026-07-29.